Johnson and Johnson, a leading manufacturer of healthcare products, had a return on equity in 2022 of 35%, and paid out 40% of its earnings as dividends. It earned a net income of $1,625 million on a book value of equity of $5,171 million. As a consequence of healthcare reform, it is expected that the return on equity will drop to 22% in 2023 and that the dividend payout ratio will remain unchanged. Lay out details and steps for the following questions: A. Estimate the growth rate in earnings based upon 2022 numbers alone B. Estimate the growth rate in 2023, when the ROE drops from 35% to 22%.